MedPath

SINUSYS CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 1
1 (50.0%)

SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study

Not Applicable
Completed
Conditions
Sinusitis
First Posted Date
2015-06-04
Last Posted Date
2016-12-13
Lead Sponsor
SinuSys Corporation
Target Recruit Count
30
Registration Number
NCT02463279
Locations
🇺🇸

Upland ENT, Upland, California, United States

🇺🇸

Colorado ENT, Denver, Colorado, United States

🇺🇸

St. Elizabeth Medical Center, Brighton, Massachusetts, United States

Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium

Phase 1
Completed
Conditions
Sinusitis
First Posted Date
2012-06-19
Last Posted Date
2014-11-05
Lead Sponsor
SinuSys Corporation
Target Recruit Count
36
Registration Number
NCT01623050
Locations
🇺🇸

Valley ENT, Tucson, Arizona, United States

🇺🇸

Palo Alto Medical Foundation, Palo Alto, California, United States

🇺🇸

St. Elizabeth Medical Center, Boston, Massachusetts, United States

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.